Abstract
Naturally occurring antioxidants such as vitamin E, β-carotene, and vitamin C can inhibit the oxidative modification of low density lipoproteins. This action could positively influence the atherosclerotic process and, as a consequence, the progression of coronary heart disease. A wealth of experimental studies provide a sound biological rationale for the mechanisms of action of antioxidants, whereas epidemiologic studies strongly sustain the “antioxidant hypothesis”. To date, however, clinical trials with β-carotene supplements have been disappointing, and their use as a preventive intervention for cancer and coronary heart disease should be discouraged. Only scanty data from clinical trials are available for vitamin C. As to vitamin E, discrepant results have been obtained by the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study with a low-dose vitamin E supplementation (50 mg/d) and the Cambridge Heart Antioxidant Study (400–800 mg/d). The results of the GISSI-Prevenzione (300 mg/d) and HOPE (400 mg/d) trials suggest the absence of relevant clinical effects of vitamin E on the risk of cardiovascular events. Currently ongoing are several large-scale clinical trials that will help in clarifying the role of vitamin E in association with other antioxidants in the prevention of atherosclerotic coronary disease.
Similar content being viewed by others
Abbreviations
- ATBC trial:
-
Alpha-Tocopherol, Beta Carotene trial
- GARET:
-
β-Carotene and Retinol Efficacy cancer prevention Trial
- CHAOS:
-
Cambridge Heart Antioxidant Study
- CHD:
-
coronary heart disease
- CI:
-
confidence interval
- CVD:
-
cardiovascular disease
- GISSI:
-
Gruppo Italiano per lo Studio della Sopravyivenza nell'Infarto Miocardio
- HOPE:
-
Heart Outcomes Prevention Evaluation
- IHD:
-
ischemic heart disease
- LDL:
-
low density lipoprotein
- MI:
-
myocardial infarction
- OR:
-
odds ratio
- PHS:
-
Physicians' Health Study
References
Braunwald, E. (1998) Evolution of the Management of Acute Myocardial Infarction: A 20th Century Saga, Lancet 352, 1771–1774.
GISSI-Avoidable Delay Study Group (1995) Epidemiology of Avoidable Delay in the Care of Acute Myocardial Infarction Patients in Italy: A GISSI Generated Study, Arch. Intern. Med. 155, 1481–1488.
Fox, R. (1997) Trends in Cardiovascular Mortality in Europe, Circulation 96, 3817–3818.
Oliver, M.F. (1995) Antioxidant Nutrients, Atherosclerosis, and Coronary Heart Disease, Br. Heart J. 73, 299–301.
Jha, P., Flather, M., Lonn, E., Farkouh, M., and Yusuf, S. (1995) The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiological and Clinical Trial Data, Ann. Intern. Med. 123, 860–872.
Morrow, D.A. (1998) Where Are We with Vitamin E? J. Thromb. Thrombolysis 5, 209–214.
Lonn, E., and Yusuf, S. (1997) Is There a Role for Antioxidant Vitamins in the Prevention of Cardiovascular Disease? An Update on Epidemiological and Clinical Trials Data, Can. J. Cardiol. 13, 957–965.
Omenn, G.S. (1998) Interpretation of the Linxian Vitamin Supplement Chemoprevention Trials, Epidemiology 9, 1–4.
Gaziano, J.M. (1994) Antioxidant Vitamins and Coronary Heart Disease Risk, Am. J. Med. 97, 18S-21S.
Stephens, N. (1997) Anti-Oxidant Therapy for Ischaemic Heart Disease: Where Do We Stand? Lancet 349, 1710–1711.
Hoffman, R.M., and Garewal, H.S. (1995) Antioxidants and the Prevention of Coronary Heart Disease, Arch. Intern. Med. 155, 241–246.
Nestel, P.J. (1995) Controlling Coronary Risk Through Nutrition, Can. J. Cardiol. 11, 9G-14G.
Hennekens, C.H., Gaziano, J.M., Manson, J.E., and Buring, J.E. (1995) Antioxidant Vitamin-Cardiovascular Disease Hypothesis Is Still Promising, but Still Unproven: The Need for Randomized Trials, Am. J. Clin. Nutr. 62 (Suppl. 6), 1377S-1380S.
Diaz, M.N., Frei, B., Vita, J.A., and Keaney, J.F., Jr. (1997) Antioxidants and Atherosclerotic Heart Disease, N. Engl. J. Med. 337, 408–416.
Lonn, E.M., and Yusuf, S. (1997) Is There a Role for Antioxidant Vitamins in the Prevention of Cardiovascular Diseases? An Update on Epidemiological and Clinical Trials Data, Can. J. Cardiol. 13, 957–965.
Hercberg, S., Galan, P., Preziosi, P., Alfarez, M.J., and Vasquez, C. (1998) The Potential Role of Antioxidant Vitamins in Preventing Cardiovascular Diseases and Cancers, Nutrition 14, 513–20.
Tribble, D.L. (1999) Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and β-Carotene. A Statement for Healtheare Professionals from the American Heart Association, Circulation 99, 591–595.
Mancini, M., Parfitt, V.J., and Rubba, P. (1995) Antioxidants in the Mediterranean Diet, Can. J. Cardiol. 11, 105G-109G.
Stampfer, M.J., and Rimm, E.B. (1995) Epidemiological Evidence for Vitamin E in Prevention of Cardiovascular Disease, Am. J. Clin. Nutr. 62, 1365S-1369S.
Marchioli, R., and Di Pasquale, A. (1993) Il Quadro di Riferimento Biochimico, Farmacologico, Epidemiologico del GISSI-Prevenzione, G. Ital. Cardiol. 23, 933–964.
Marchioli, R., and Schweiger, C. (1994) Vitamine Antiossidanti nella Prevenzione Primaria e Secondaria della Cardiopatia Ischemica, in Cardiologia, pp. 551–569, Scientific Press Edition, Milano.
Marchioli, R. (1998) Antiossidanti Farmaci, in Enciclopedia Medica Italiana, Agg. II, Tomi I, pp. 474–490, UTET, Torino.
Marchioli, R. (1999) Antioxidant Vitamins and Prevention of Cardiovascular Disease: Laboratory, Epidemiological and Clinical Trial Data, Pharmacol. Res. 40, 227–238.
Onori, L., Ciccocioppo, R., and Saltarelli, P. (1992) Metaboliti Reattivi dell'Ossigeno in Medicina Interna, Fed. Med. 5, 31–38.
Steinberg, D. (1991) Antioxidants and Atherosclerosis. A Current Assessment, Circulation 84, 1420–1425.
Duthie, G.G., Wahle, K.W.J., and James, W.P.T. (1989) Oxidants, Antioxidants and Cardiovascular Disease, Nutr. Res. Rev. 2, 51–62.
Steinberg, D., and Workshop Participants (1992) Antioxidants in the Prevention of Human Atherosclerosis, Circulation 85, 2337–2344.
Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., and Witztum, J.L. (1989) Beyond Cholesterol. Modifications of Low-Density Lipoprotein That Increase Its Atherogenicity, N. Engl. J. Med. 320, 915–924.
Duthie, G.G., Wahle, K.W.J., and James, W.P.T. (1989) Oxidants, Antioxidants and Cardiovascular Disease, Nutr. Res. Rev. 2, 51–62.
Sullivan, J.L. (1991) Antioxidants and Coronary Heart Disease, Lancet 337, 432–433.
Esterbauer, H., Gebicki, J., Puhl, H., and Jurgens, G. (1992) The Role of Lipid Peroxidation and Antioxidants in Oxidative Modification of LDL, Free Radic. Biol. Med. 13, 341–390.
Steinberg, D., and Witztum, J.L. (1990) Lipoproteins and Atherogenesis. Current Concepts, J. Am. Med. Assoc. 264, 3047–3052.
Ross, R. (1992) The Pathogenesis of Atherosclerosis, in Heart Disease. A Textbook of Cardiovascular Medicine, (Braunwald, E., ed.), 4th edn., pp. 1106–1124, W.B. Saunders Company, Philadelphia.
Burton, G.W., and Traber, M.G. (1990) Vitamin E: Antioxidant Activity, Biokinetics, and Bioavailability, Annu. Rev. Nutr. 10, 357–382.
Stampfer, M.J., Willett, W., Castelli, W.P., Taylor, J.O., Fine, J., and Hennekens, C.H. (1983) Effect of Vitamin E on Lipids, Am. J. Clin. Pathol. 79, 714–716.
Esterbauer, H., Dieber-Rotheneder, M., Striegl, G., and Waeg, G. (1991) Role of Vitamin E in Preventing the Oxidation of Low-Density Lipoprotein, Am. J. Clin. Nutr. 53, 314S-321S.
Frei, B., Stocker, R., and Ames, B.N. (1988) Antioxidant Defenses and Lipid Peroxidation in Human Blood Plasma, Proc. Natl. Acad. Sci. USA 85, 9748–9752.
Avogaro, P., Bon, G.B., Cazzolato, G. (1988) Presence of a Modified Low Density Lipoprotein in Humans, Artcriosclerosis 8, 79–87.
Esterbauer, H., Gebicki, J., Puhl, H., and Jurgens, G. (1992) The Role of Lipid Peroxidation and Antioxidants in Oxidative Modification of LDL, Free Radic. Biol. Med. 13, 341–390.
Diaz, M.N., Frei, B., Vita, J.A., and Keaney, J.F. (1997) Antioxidants and Atherosclerotic Heart Disease, N. Engl. J. Med. 337, 408–416.
Quinn, M.T., Parthasarathy, S., and Steinberg, D. (1985) Endothelial Cell-Derived Chemotactic Activity for Mouse Peritoneal Macrophages and the Effects of Modified Forms of Low Density Lipoprotein, Proc. Natl. Acad. Sci. USA 82, 5949–5953.
Quinn, M.T., Parthasarathy, S., Fong, L.G., and Steinberg, D. (1987) Oxidatively Modified Low Density Lipoproteins: A Potential Role in Recruitment and Retention of Monocyte/Macrophages During Atherogenesis, Proc. Natl. Acad. Sci. USA 84, 2995–2998.
Frostergard, J., Haegerstrand, A., Gidlund, L., and Nilsson, J. (1991) Biologically Modified LDL Increases the Adhesive Properties of Endothelial Cells, Atherosclerosis 90, 119–126.
Levine, G.N., Keaney, J.F., and Vita, J.A. (1995) Cholesterol Reduction in Cardiovascular Disease: Clinical Benefits and Possible Mechanisms, N. Engl. J. Med. 332, 512–521.
Nagano, Y., Arai, H., and Kita, T. (1991) High Density Lipoprotein Loses Its Effect to Stimulate Efflux of Cholesterol from Foam Cells After Oxidative Modification, Proc. Natl. Acad. Sci. USA 88, 6457–6461.
Reaven, P.D., and Witztum, J.L. (1993) Comparison of Supplementation of RRR-α-Tocopherol and Racemic α-Tocopherol in Humans. Effects on Lipid Levels and Lipoprotein Susceptibility to Oxidation, Arterioscler. Thromb. 13, 601–608.
Reaven, P.D., Khouw, A., Beltz, W.F., Parthasarathy, S., and Witztum, J.L. (1993) Effect of Dietary Antioxidant Combinations in Humans. Protection of LDL by Vitamin E but Not by β-Carotene, Arterioscler Thromb 13, 590–600.
Carew, T.E., Schwenke, D.C., and Steinberg D. (1987) Antiatherogenic Effect of Probucol Unrelated to Its Hypocholesterolemic Effect: Evidence That Antioxidants in vivo Can Selectively Inhibit Low Density Lipoprotein Degradation in Macrophage-Rich Fatty Streaks and Slow the Progression of Atherosclerosis in the Watanabe Heritable Hyperlipidemic Rabbit, Proc. Natl. Acad. Sci. USA 84, 7725–7729.
Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Ooshima, A., Yoshida, H., and Kawai, C. (1987) Probucol Prevents the Progression of Atherosclerosis in Watanabe Heritable Hyperlipidemic Rabbit, an Animal model for Familial Hypercholesterolemia, Proc. Natl. Acad. Sci. USA 84, 5928–5931.
Gey, K.F., Moser, U.K., Jordan, P., Stähelin, H.B., Eichholzer, M., and Lüdin, E. (1993) Increased Risk of Cardiovascular Disease at Suboptimal Plasma Concentrations of Essential Antioxidants: An Epidemiological Update with Special Attention to Carotene and Vitamin C, Am. J. Clin. Nutr. 57 (Suppl.), 787S-797S.
Jalal, I., Freeman, D.A., and Grundy, S.M. (1991) Varying Susceptibility of Different Low Density Lipoproteins to Oxidative Modification, Arterioscler. Thromb. 11, 482–488.
Jalal, I., and Grundy, S.M. (1992) Influence of Antioxidant Vitamins on LDL Oxidation, Ann. NY Acad. Sci. 669, 237–248.
Jalal, I., and Grundy, S.M. (1992) Combined Supplementation with Alpha-Tocopherol, Ascorbate and Beta-Carotene Inhibits LDL Oxidation, Circulation 86, 462.
Haberland, M.E., Fong, D., and Cheng, L. (1988) Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritble Hyperlipidemic Rabbits, Science 241, 215–218.
Palinski, W., Rosenfeld, M.E., Yla-Herttuala, S., Gurtner, G.C., Socher, S.S., Butler, S.W., Parthasarathy, S., Carew, T.E., Steinberg, D., and Witztum, J.L. (1989) Low Density Lipoprotein Undergoes Oxidative Modification in vivo, Proc. Natl. Acad. Sci. USA 86, 1372–1376.
Salmon, S., Maziere, C., Theron, L., Beucler, I., Ayrault-Jarrier, M., Goldstein, S., and Polonovski, J. (1987) Immunological Detection of Low Density Lipoproteins Modified by Malondialdehyde in vitro or in vivo, Biochim. Biophys. Acta 920, 215–220.
Kleijnen, J., Knipschild, P., and ter Riet, G. (1989) Vitamin E and Cardiovascular Disease, Eur. J. Clin. Pharmacol. 37, 541–544.
Chin, J.H., Azhar, S., and Hoffman, B.B. (1992) Inactivation of Endothelial Derived Relaxing Factor by Oxidised Lipoproteins, J. Clin. Investig. 89, 10–18.
Kugiyama, K., Kerns, S.A., Morriset, J.D., Roberts, R., and Henry, P.D. (1990) Impairment of Endothelium-Dependent Arterial Relaxation by Lysolecithin in Modified Low-Density Lipoproteins, Nature 344, 160–162.
Kugiyama, K., Ohgushi, M., Sugiyama, S., Murohara, T., Fukunaga, K., Miyamoto, E., and Yasue, H. (1992) Lyso-phosphatidylcholine Inhibits Surface Receptor-Mediated Intracellular Signals in Endothelial Cells by a Pathway Involving Protein Kinase C Activation, Circ. Res. 71, 1422–1428.
Anderson, T.J., Meredith, I.T., Charbonneau, F., Yeung, A.C., Frei, B., Selwyn, A.P., and Ganz, P. (1996) Endothelium-Dependent Coronary Vasomotion Relates to Susceptibility of LDL to Oxidation in Humans, Circulation 93, 1647–1650.
Faruqi, R., de la Motte, C., and DiCorleto, P.E. (1994) Alpha-Tocopherol Inhibits Agonist-Induced Monocytic Cell Adhesion to Cultured Endothelial Cells, J. Clin. Investig. 94, 592–596.
Plane, F., Jacobs, M., McManus, D., and Bruckdorfer, K.R. (1993) Probucol and Other Antioxidants Prevent the Inhibition of Endothelium-Dependent Arterial Relaxation by Low Density Lipoproteins, Atherosclerosis 103, 73–79.
Davi, G., Gresele, P., Violi, F., Basili, S., Catalano, M., Giammarresi, C., Volpato, R., Nenci, G.G., Ciabattoni, G., and Patrono, C. (1997) In Vivo Formation of 8-epi-Prostaglandin F2α Is Increased in Hypercholesterolemia, Arterioscler. Thromb. Vasc. Biol. 17, 3230–3235.
Patrono, C., and FitzGerald, G.A. (1997) Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease, Arterioscler. Thromb. Vasc. Biol. 17, 2309–2315.
Patrignani, P., Santini, G., Panara, M.R., Sciulli, M.G., Greco, A., Rotondo, M.T., di Giamberardino, M., Maclouf, J., Ciabattoni, G., and Patrono, C. (1996) Induction of Prostaglandin Endoperoxide Synthase-2 in Human Monocytes Associated with Cyclo-Oxygenase-Dependent F2-Isoprostane Formation, Br. J. Pharmacol. 118, 1285–1293.
Mehra, M.R., Lavie, C.J., Ventura, H.O., and Milani, R.V. (1995) Prevention of Atherosclerosis: The Potential Role of Antioxidants, Postgrad. Med. 98, 175–184.
Harats, D., Ben-Naim, M., Dabach, Y., Hollander, G., Stein, O., and Stein, Y. (1989) Cigarette Smoking Renders LDL Susceptible to Peroxidative Modification and Enhanced Metabolism by Macrophages, Atherosclerosis 79, 245–252.
Babiy, A.V., Gebicki, J.M., Sullivan, D.R., and Willey, K. (1992) Increased Oxidability of Plasma Lipoproteins in Diabetic Patients Can Be Decreased by Probucol Therapy and Is Not Due to Glycation, Biochem. Pharmacol. 43, 995–1000.
Petitti, D.B. (1994) Meta-Analysis, Decision Analysis, and Costeffectiveness Analysis, Oxford University Press, New York.
Greenland, S. (1987) Quantitative Methods in the Review of Epidemiological Literature, Epidemiol Rev. 39, 1–30.
Rimm, E.B., Stampfer, M.J., Ascherio, A., Giovannucci, E., Colditz, G.A., and Willett, W.C. (1993) Vitamin E Consumption and the Risk of Coronary Heart Disease in Men, N. Engl. J. Med. 328, 1450–1456.
Stampfer, M.J., Hennekens, C.H., Manson, J.E., Colditz, G.A., Rosner, B., and Willett, W.C. (1993) Vitamin E Consumption and the Risk of Coronary Disease in Women, N. Engl. J. Med. 328, 1444–1449.
Kushi, L.H., Folsom, A.R., Prineas, R.J., Mink, P.J., Wu, Y., and Bostick, R.M. (1996) Dietary Antioxidant Vitamins and Death from Coronary Heart Disease in Postmenopausal Women, N. Engl. J. Med. 334, 1156–1162.
Knekt, P., Reunanen, A., Jarvinen, R., Seppanen, R., Heliovaara, M., and Aromaa, A. (1994) Antioxidant Vitamin Intake and Coronary Mortality in a Longitudinal Population Study, Am. J. Epidemiol. 139, 1180–1189.
Gaziano, J.M., Manson, J.E., Branch, L.G., Colditz, G.A., Willett, W.C., and Buring, J.E. (1995) A Prospective Study of Consumption of Carotenoids in Fruits and Vegetables and Decreased Cardiovascular Mortality in the Elderly, Ann. Epidemiol. 5, 255–260.
Gey, K.F., Moser, U.K., Jordan, P., Stähelin, H.B., Eichholzer, M., and Lüdin, E. (1993) Increased Risk of Cardiovascular Disease at Suboptimal Plasma Concentrations of Essential Antioxidants: An Epidemiological Update with Special Attention to Carotene and Vitamin C, Am. J. Clin. Nutr. 57 (Suppl.), 787S-797S.
Morris, D.L., Krichevsky, S.B., and Davis, C.E. (1994) Serum Carotenoids and Coronary Heart Disease: The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-Up Study, J. Am. Med. Assoc. 272, 1439–1441.
Kardinaal, A.F., Kok, F.J., Ringstad, J., Gomez-Aracena, J., Mazaev, V.P., Kohlmeier, L., Martin, B.C., Aro, A., Kark, J.D., Delgado-Rodriguez, M., et al. (1993) Antioxidants in Adipose Tissue and Risk of Myocardial Infarction: The Euramic Study, Lancet 342, 1379–1384.
Salonen, J.T., Salonen, R., Penttilä, I., Herranen, J., Jauhiainen, M., Kantola, M., Lappetelainen, R., Maenpaa, P.H., Alfthan, G., and Puska, P. (1985) Serum Fatty Acids, Apolipoproteins, Selenium and Vitamin Antioxidants and the Risk of Death from Coronary Artery Disease, Am. J. Cardiol. 56, 226–231.
Kok, F.J., de Bruijn, A.M., Vermeeren, R., Hofman, A., van Laar, A., de Bruin, M., Hermus, R.J., and Valkenburg, H.A. (1987) Serum Selenium Vitamin Antioxidants, and Cardiovascular Mortality: A 9-Year Follow-up Study in the Netherlands, Am. J. Clin. Nutr. 45, 462–468.
Street, D.A., Comstock, G.W., Salkeld, R.M., Schuep, W., and Klag, M.J. (1994) Serum Antioxidants and Myocardial Infarction: Are Low Levels of Carotenoids and α-Tocopherol Risk Factors for Myocardial Infarction? Am. J. Clin. Nutr. 90, 1154–1161.
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers, N. Engl. J. Med. 330, 1029–1035.
Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R., Glass, A., Keogh, J.P., Meyskens, F.L., Valanis, B., Williams, J.H., et al. (1996) Effects of Beta-Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease, N. Engl. J. Med. 334, 1150–1155.
Hennekens, C.H., Buring, J.E., Manson, J.E., Stampfer, M., Rosner, B., Cook, R.R., Belanger, C., LaMotte, F., Gaziano, J.M. Ridker, P.M., et al. (1996) Lack of Effect of Long-Term Supplementation with Beta-Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease, N. Engl. J. Med. 334, 1145–1149.
Gaziano, J.M., Manson, J.E., Ridker, P.M., Buring, J.E., and Hennekens, C.H. (1990) Beta Carotene Therapy for Chronic Stable Angina, Circulation 82 (Suppl. III), 201 (Abstr.)
Greenberg, E.R., Baron, J.A., Tosteson, T.D. Freeman, D.H., Jr., Beck, G.J., Bond, J.H., Colacchio, T.A., Coller, J.A., Frankl, H.D., Haile, R.W., et al. (1994) A Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma, N. Engl. J. Med. 331, 141–147.
Greenberg, E.R., Baron, J.A., Stukel, T.A., Stevens, M.M., Mandel, J.S., Spencer, S.K., Elias, P.M., Lowe, N., Nierenberg, D.W., Bayrd, G., et al. (1990)_A Clinical Trial of Beta-Carotene to Prevent Basal-Cell and Squamous-Cell Cancers of the Skin. The Skin Cancer Prevention Study Group, N. Engl. J. Med. 323, 789–795.
Enstrom, J.E., Kanim, L.E., and Klein, M.A. (1992) Vitamin C Intake and Mortality Among a Sample of the United States Population, Epidemiology 3, 194–202.
Enstrom, J.E., Kanim, L.E., and Breslow, L. (1986) The Relationship Between Vitamin C Intake, General Health Practices, and Mortality in Alameda County, California, Am. J. Public Health 76, 1124–1130.
Gale, C.R., Martyn, C.N., Winter, P.D., and Cooper, C. (1995) Vitamin C and Risk of Death from Stroke and Coronary Heart Disease in Cohort of Elderly People, Br. Med. J. 310, 1563–1566.
Gey, K.F., Stähelin, H.B., Puska, P., and Evans, A. (1987) Relationship of Plasma Level of Vitamin C to Mortality from Ischemic Heart Disease, Ann. NY Acad. Sci. 498, 110–123.
Gey, K.F., Puska, P., Jordan, P., and Moser, U.K. (1991) Inverse Correlation Between Plasma Vitamin E and Mortality from Ischaemic Heart Disease in Cross-Cultural Epidemiology, Am. J. Clin. Nutr. 53, 326S-334S.
Blot, W.J., Li, J.Y., Taylor, P.R., Guo, W., Dawsey, S., Wang, G.Q., Yang, C.S., Zheng, S.F., Gail, M., Li, G.Y., et al. (1993) Nutrition Intervention Trials in Linxian, China: Supplementation with Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-Specific Mortality in the General Population, J. Natl. Cancer Inst. 85, 1483–1492.
Wilson, T.S., Datta, S.B., Murrel, J.S., and Andrews, C.T. (1973) Relation of Vitamin C Levels to Mortality in a Geriatric Hospital: A Study of the Effect of Vitamin C Administration, Age Aging 2, 163–171.
Salonen, J.T., Salonen, R., Seppanen, K., Kantola, M., Parviainen, M., Alfthan, G., Maenpaa, P.H., Taskinen, E., and Rauramaa, R. (1988) Relationship of Serum Selenium and Antioxidants to Plasma Lipoproteins, Platelet Aggregability and Prevalent Ischaemic Heart Disease in Eastern Finnish Men, Atherosclerosis 70, 155–160.
Riemersma, R.A., Oliver, M., Elton R.A., Alfthan, G., Vartiainen, E., Salo, M., Rubba, P., Mancini, M., Georgi, H., Vuilleumier, J.P., et al. (1990) Plasma Antioxidants and Coronary Heart Disease: Vitamins C and E, and Selenium, Eur. J. Clin. Nutr. 44, 143–150.
Stringer, M.D., Görög, P.G., Freeman, A., and Kakkar, V.V. (1989) Lipid Peroxides and Atherosclerosis, Br. Med. J. 298, 281–284.
Riemersma, R.A., Wood, D.A., Macintyre, C.C.A., Elton, R.A., Gey, K.F., and Oliver, M.F. (1991) Risk of Angina Pectoris and Plasma Concentrations of Vitamins A, C, and E and Carotene, Lancet 337, 1–5.
DeMaio, S.J., King, S.B., Lembo, N.J., Roubin, G.S., Hearn, J.A., Bhagavan, H.N., and Sgoutas, D.S. (1992) Vitamin E Supplementation. Plasma Lipids and Incidence of Restenosis After Percutaneous Transluminal Coronary Angioplasty (PTCA), J. Am. Coll. Nutr. 11, 68–73.
Stephens, N.G., Parsons, A., Schofield, P.M., Kelly, F., Cheeseman, K., and Mitchinson, M.J. (1996) Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet 347, 781–786.
GISSI-Prevenzione Investigators (1999) Dietary Supplementation with n−3 Polyunsaturated Fatty Acids and Vitamin E After Myocardial Infarction: Results of the GISSI-Prevenzione Trial, Lancet 354, P447-P455.
The HOPE (Heart Outcomes Prevention Evaluation) Study Investigators Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients, (2000) N. Engl. J. Med. 342, 154–160.
Rapola, J.M., Virtamo, J., Ripatti, S., Huttunen, J.K., Albanes, D., Taylor, P.R., and Heinonen, O.P. (1997) Randomised Trial of α-Tocopherol and β-Carotene Supplements on the Incidence of Major Coronary Events in Men with Previous Myocardial Infarction, Lancet 349, 1715–1720.
Steinberg, D. (1995) Clinical Trials of Antioxidants in Atherosclerosis: Are We Doing the Right Things? Lancet 346, 36–38.
Verlangieri, A.J., and Bush, M.J. (1992) Effects of d-α-Tocopherol Supplementation on Experimentally Induced Primate Atherosclerosis, J. Am. Coll. Nutr. 11, 131–138.
Keaney, J.F., Simon, D.I., and Freedman, J.E. (1999) Vitamin E and Vascular Homeostasis: Implications for Atherosclerosis, FASEB J. 13, 965–976.
Törnwall, M.E., Virtamo, J., Haukka, J.K., Aro, A., Albanes, D., and Huttunen, J.K. (1999) The Effect of Alpha-Tocopherol and Beta-Carotene Supplementation on Symptoms and Progression of Intermittent Claudication in a Controlled Trial, Atherosclerosis 147, 193–197.
Hercberg, S., Preziosi, P., Briançon, S., Galan, P., Triol, I., Malvy, D., Roussel, A.M., and Favier, A. (1998) A Primary Prevention Trial Using Nutritional Doses of Antioxidant Vitamins and Minerals in Cardiovascular Diseases and Cancers in a General Population: The SU.VI.MAX Study—Design, Methods and Participants' Characteristics, Control. Clin. Trials 19, 336–351.
Singh, R.B., Niaz, M.A., Rastogi, S.S., and Rastogi, S. (1996) Usefulness of Antioxidant Vitamins in Suspected Acute Myocardial Infarction (The Indian Experiemnt of Infarct Survival-3), Am. J. Cardiol. 77, 232–236.
Vollset, S.E., and Bjelke, E. (1983) Does Consumption of Fruit and Vegetables Protect Against Stroke? Lancet 2, 742 (letter).
Marchioli, R., Bomba, E., and Tognoni, G. (1996) Sheffield Risk and Treatment Table for Cholesterol Lowering in Prevention of Coronary Heart Disease, Lancet 347, 467–468.
Artaud-Wild, S.M., Connor, S.L., Sexton, G., and Connor, W.E. (1993) Differences in Coronary Mortality Can Be Explained by Differences in Cholesterol and Saturated Fat Intakes in 40 Countries but Not in France and Finland. A Paradox, Circulation 88, 2771–2779.
Hertog, M.G., Kromhout, D., Aravanis, C., Blackburn, H., buzina, R., Fidanza, F., Giampaoli, S., Jansen, A., Menotti, A., Nedeljkovic, S., et al. (1995) Flavonoid Intake and Longterm Risk of Coronary Heart Disease and Cancer in the Seven Countries Study, Arch. Intern. Med. 155, 381–386.
Hertog, M.G.L., Feskens, E.J.M., Hollman, P.C.H., Katan, M.B., and Kromhout, D. (1993) Dietary Antioxidant Flavonoids and Risk of Coronary Heart Disease: The Zutphen Elderly Study. Lancet 342, 1007–1011.
Marchioli, R., and Tognoni, G. (1996) Beneficial Effects of Statins, Lancet 348, 1542.
Clarke, R., Frost, C., Collins, R., Appleby, P., and Peto, R. (1997) Dietary Lipids and Blood Cholesterol: Quantitative Meta-Analysis of Metabolic Ward Studies, Br. Med. J. 314, 112–117.
Ebrahim, S., and Davey Smith, G. (1997) Systematic Review of Randomised Controlled Trials of Multiple Interventions for Preventing Coronary Heart Disease, Br. Med. J. 314, 1666–1674.
Tang, J.L., Armitage, J.M., Lancaster, T. Silagy, C.A., Fowler, G.H., and Neil, H.A.W. (1998) Systematic Review of Dietary Intervention Trials to Lower Blood Total Cholesterol in Free-Living Subjects, Br. Med. J. 316, 1213–1220.
Hu, F.B., Stampfer, M.J., Manson, J.F., Rimm, E., Colditz, G.A., Rosner, B.A., Hennekens, C.H., and Willett, W.C. (1997) Dietary Fat Intake and the Risk of Coronary Heart Disease in Women, N. Engl. J. Med. 337, 1491–1499.
Weindruch, R., and Sohal, R.S. (1997) Caloric Intake and Aging, J. Engl. J. Med. 337, 987–994.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Marchioli, R., Schweiger, C., Levantesi, G. et al. Antioxidant vitamins and prevention of cardiovascular disease: Epidemiological and clinical trial data. Lipids 36 (Suppl 1), S53–S63 (2001). https://doi.org/10.1007/s11745-001-0683-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-001-0683-y